Version July 2025
| Cryptogenic cirrhosis |
| Postnecrotic cirrhosis |
| Alcoholic cirrhosis |
| Autoimmune cirrhosis (and hepatitis) |
| Primary biliary cholangitis |
| Chronic active hepatitis |
| Primary sclerosing cholangitis |
| Alpha-1 antitrypsin deficiency (associated with Z and M-malton, and Siiyama alleles) |
| Wilson disease |
| Sarcoidosis[1] |
| Hemochromatosis |
| Biliary atresia |
| Noncirrhotic portal hypertension |
| Tyrosinemia |
| Gaucher disease |
| Schistosomiasis |
| Nodular regenerative hyperplasia of the liver |
| Hepatic allograft rejection |
| Langerhans-cell histiocytosis |
| Hepatic graft-versus-host disease following hematopoietic stem cell transplantation |
| Short telomere syndrome |
| Budd Chiari Syndrome |
| Chronic granulomatous hepatitis |
| Some acute liver diseases |
| Congenital vascular disease (eg, cavopulmonary shunt, Abernethy malformation) |
Adapted from: Krowka MJ. Clinical management of hepatopulmonary syndrome. Semin Liver Dis 1993; 13:414.
